Barclays PLC Johnson & Johnson Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Johnson & Johnson stock. As of the latest transaction made, Barclays PLC holds 8,307,302 shares of JNJ stock, worth $1.28 Billion. This represents 0.46% of its overall portfolio holdings.

Number of Shares

8,307,302

Previous 31,000 26697.75%

Holding current value

$1.28 Billion

Previous $4.86 Million 26945.28%

% of portfolio

0.46%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $99.1 Million - $104 Million	-638,239 Reduced 7.13%	8,307,302 $1.31 Billion
Q4 2023 Feb 15, 2024	SELL	$145.6 - $158.88 $341 Million - $372 Million	-2,341,936 Reduced 20.75%	8,945,541 $1.4 Billion
Q3 2023 Nov 07, 2023	SELL	$155.75 - $174.48 $44,856 - $50,250	-288 Reduced -0.0%	11,287,477 $1.76 Billion
Q2 2023 Aug 03, 2023	BUY	$154.35 - $166.11 $627 Million - $674 Million	4,059,112 Added 56.15%	11,287,765 $1.87 Billion
Q1 2023 May 04, 2023	SELL	$151.05 - $180.26 $603 Million - $720 Million	-3,995,221 Reduced 35.6%	7,228,653 $1.12 Billion

Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $696 Million - $781 Million	4,344,809 Added 63.16%	11,223,874 $1.98 Billion
Q3 2022 Nov 03, 2022	BUY	$161.33 - $179.52 $333 Million - $371 Million	2,064,530 Added 42.88%	6,879,065 $1.12 Billion
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $291 Million - $322 Million	-1,731,717 Reduced 26.45%	4,814,535 $855 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $414 Million - $471 Million	-2,620,967 Reduced 28.59%	6,546,252 $1.16 Billion
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $129 Million - $143 Million	-827,471 Reduced 8.28%	9,167,219 $1.57 Billion
Q3 2021 Nov 09, 2021	BUY	$161.5 - $179.47 $558 Million - $620 Million	3,456,063 Added 52.86%	9,994,690 $1.61 Billion
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $237 Million - $254 Million	1,486,048 Added 29.41%	6,538,627 $1.08 Billion
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $115 Million - $129 Million	754,468 Added 17.55%	5,052,579 $830 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $85.5 Million - $98.1 Million	623,434 Added 16.97%	4,298,111 $676 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $88.2 Million - $96.6 Million	628,135 Added 20.62%	3,674,677 $547 Million
Q2 2020 Aug 12, 2020	SELL	$128.81 - $155.51 $52.4 Million - $63.3 Million	-407,082 Reduced 11.79%	3,046,542 $428 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $211 Million - $293 Million	-1,901,265 Reduced 35.51%	3,453,624 $453 Million
Q4 2019 Feb 10, 2020	SELL	$127.5 - $146.44 $168 Million - $193 Million	-1,316,832 Reduced 19.74%	5,354,889 $781 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $66.6 Million - $74.5 Million	524,418 Added 8.53%	6,671,721 $863 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $138 Million - $151 Million	1,049,887 Added 20.6%	6,147,303 $856 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $69 Million - $76.7 Million	548,493 Added 12.06%	5,097,416 $713 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $69.9 Million - $84.1 Million	568,792 Added 14.29%	4,548,923 $587 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $6.61 Million - $7.76 Million	54,343 Added 1.38%	3,980,131 $550 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $113 Million - $125 Million	-946,389 Reduced 19.42%	3,925,788 $476 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $11.9 Million - $14.1 Million	95,272 Added 1.99%	4,872,177 $624 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $284 Million - $311 Million	2,162,028 Added 82.68%	4,776,905 $667 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $339 Million - $354 Million	2,614,877	2,614,877 $340 Million

Others Institutions Holding JNJ

# of Institutions

4,139

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account